IRIS
FERRARO, Giuseppa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.509
EU - Europa 1.285
AS - Asia 423
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.220
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.505
SE - Svezia 397
IE - Irlanda 352
CN - Cina 234
SG - Singapore 151
IT - Italia 105
UA - Ucraina 95
DE - Germania 74
FR - Francia 59
FI - Finlandia 55
PL - Polonia 52
GB - Regno Unito 43
IN - India 21
BE - Belgio 18
AT - Austria 17
RU - Federazione Russa 9
VN - Vietnam 7
CA - Canada 4
ID - Indonesia 3
CZ - Repubblica Ceca 2
IR - Iran 2
JP - Giappone 2
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
LV - Lettonia 1
NO - Norvegia 1
PH - Filippine 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 3.220
Salva come PNG Salva come JPEG
Città #
Dublin 352
Chandler 309
Nyköping 205
Jacksonville 196
Singapore 125
Ashburn 119
Beijing 91
Ann Arbor 63
New York 61
Dearborn 58
Warsaw 52
Cambridge 51
Princeton 51
Medford 49
Des Moines 42
Messina 38
Boardman 34
Jinan 25
Woodbridge 22
Brussels 18
San Mateo 17
Vienna 17
Lancaster 16
Pune 16
Shenyang 14
Wilmington 13
Tianjin 12
Nanjing 11
Hebei 10
Los Angeles 10
Zhengzhou 10
Houston 8
Dong Ket 7
Grammichele 6
Guangzhou 6
Ningbo 6
Augusta 5
Changsha 5
Fort Washington 5
Helsinki 5
Taizhou 5
Fuzhou 4
Haikou 4
Lanzhou 4
Leawood 4
London 4
Washington 4
Auburn Hills 3
Brockport 3
Catania 3
Hangzhou 3
Hyderabad 3
Jakarta 3
Jiaxing 3
Milan 3
Monmouth Junction 3
Nanchang 3
Norwalk 3
Santa Clara 3
Seattle 3
Taiyuan 3
Tappahannock 3
Trepuzzi 3
Anagni 2
Bremen 2
Brooklyn 2
Falls Church 2
Forestella 2
Girifalco 2
Hefei 2
Novokuznetsk 2
Saint Petersburg 2
Toronto 2
Acireale 1
Ardabil 1
Brno 1
Changle 1
Chengdu 1
Ciampino 1
Clearwater 1
Copenhagen 1
Cupertino 1
Edinburgh 1
Fairfield 1
Foshan 1
Frankfurt am Main 1
Guiyang 1
Hillsdale 1
Jeffries 1
Johannesburg 1
Kemerovo 1
Kumamoto 1
La Paz 1
Las Vegas 1
Manila 1
Montreal 1
Montréal 1
Mountain View 1
Mumbai 1
Munich 1
Totale 2.284
Salva come PNG Salva come JPEG
Nome #
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC). 122
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 107
Nab-paclitaxel and trastuzumab combination: A promising approach for neoadjuvant treatment in HER2-positive breast cancer 92
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 92
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 88
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 83
NSCLC and HER2: between lights and shadows 83
Is the adenocarcinoma subtype a predictor of response to Pemetrexed in patients with non small cell lung cancer? Our preliminary data. 81
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases 79
Is the adenocarcinoma subtype a predictor of response to Pemetrexed in patients with non small cell lung cancer? Our preliminary data 76
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). 76
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care. 73
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 73
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 69
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 69
Metastasis risk assessment in breast cancer (BC): a preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes 69
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 66
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 65
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 65
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 64
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: 63
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 62
Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma. 61
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study) 60
Ruolo del Trastuzumab nel Trattamento Adiuvante del Carcinoma Mammario Operabile. 59
Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study. 58
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 58
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients 57
Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity 57
Incidence and preferential localizations of bone metastases: biomolecolar and clinical implications. 56
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 56
Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data. 55
Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients 55
Neoplasie della testa collo nell’ anziano 55
Early Breast Cancer HER2 positivo in postmenopausa: strategia terapeutica adiuvante 54
RANDOMISED PHASE II TERTIARY CHEMOPREVENTION TRIAL FOR COLORECTAL ADENOMA IN 24 PATIENTS WITH COLORECTAL CANCER TREATED WITH CELECOXIB 53
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 53
null 52
New biomarkers to predict response to pemetrexed-based chemotherapy in non small cell lung cancer: from 5,10-methylenetetrahydrofolate reductase promises to miRNAs revolution. 51
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 50
Ruolo di Trastuzumab nella terapia adiuvante del carcinoma mammario operabile. 49
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. 48
Correction: Androgen Receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in Triple-Negative Breast Cancer (TNBC) patients 48
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient 46
Temozolamide plus oral vinorelbine in the treatment of brain metastases from solid tumours in heavily pre- treated patients. 45
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 45
SAFETY OF PEGILATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ELDERLY WOMEN (>65 YEARS)WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER 43
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 42
Invecchiamento e cancro. 38
null 37
null 33
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 lymphnodes 32
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications 25
null 22
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 15
Totale 3.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020321 0 0 0 0 0 60 49 60 8 68 64 12
2020/2021442 37 5 105 44 32 44 17 25 15 39 53 26
2021/2022412 2 66 10 11 14 6 23 9 5 99 57 110
2022/20231.137 87 118 49 105 83 104 18 88 444 2 29 10
2023/2024313 18 50 15 27 16 124 30 17 0 4 1 11
2024/2025193 8 9 19 68 47 42 0 0 0 0 0 0
Totale 3.285